Article
BRCA1 counteracts progesterone action by ubiquitination leading to progesterone receptor degradation and epigenetic silencing of target promoters.
Cancer research - 1 May 2011
Calvo Verónica, Beato Miguel
Abstract excerpt
Germ-line mutations in the BRCA1 gene increase the risk of breast cancer in women, but the precise mechanistic basis for this connection remains uncertain. One popular hypothesis to explain breast tissue specificity postulates a link between BRCA1 and the action of the ovarian hormones estrogen and progesterone. Given the relevance of progesterone for normal mammary development and breast cancer formation, we...
Read the complete abstract on PubMedTopics
Share this publication in a Topic to start or enrich a Post.
